An update on European randomized studies in non-small cell lung cancer

Seminars in Oncology

Volumn 25, Issue 4 SUPPL., 1998, Pages 11-17

  Giaccone, G ^a   Manegold, C ^a   Rosell, R ^a   Gatzemeier, U ^a   Quoix, E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; MITOMYCIN C; NAVELBINE; PACLITAXEL; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ALOPECIA; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; EUROPE; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; EUROPE; HUMANS; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS;

EID: 0031928563     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)